Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) efficaciously reduce systolic blood pressure (BP), a well-established risk factor for myocardial infarction (MI). Both inhibit the renin-angiotensin system, albeit through different mechanisms, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Batty, Jonathan A., Tang, Mengyao, Hall, Marlous, Ferrari, Roberto, Strauss, Martin H., Hall, Alistair S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109343/
https://www.ncbi.nlm.nih.gov/pubmed/30144828
http://dx.doi.org/10.1186/s13643-018-0779-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109343/
https://www.ncbi.nlm.nih.gov/pubmed/30144828
http://dx.doi.org/10.1186/s13643-018-0779-5

Ejemplares similares